đź’ŠWill INS018_055 be FDA-approved by 2030?
Basic
3
Ṁ472030
48%
chance
1D
1W
1M
ALL
Insilico Medicine's AI-designed drug for idiopathic pulmonary fibrosis, INS018_055, has entered Phase II clinical trials. Will it become (one of) the first AI-designed drugs to get FDA approval?
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will a vaccine for HIV be approved by the FDA by 2030?
68% chance
Will AOH1996 be FDA approved before 2040?
44% chance
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
54% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
55% chance
Will FDA approve an “AI doctor” for primary care before 2030?
30% chance
Will an AI-designed drug get FDA approval by the end of 2025?
30% chance
The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
24% chance
Which of these protein targets will have at least one new drug targeting them receive FDA approval between 2025 and 2030